Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Robot researcher combines nature to nurture 'superhuman' navigation

  • Risks of opioids outweigh benefits for headache, low back pain, other conditions

  • Low social support linked to poor health in young heart attack survivors

  • EEG's potential to reveal depolarizations following TBI

  • To improve oral health of adults with developmental disabilities, improve support for caregivers

  • Gene interacts with stress, leads to heart disease in some people

  • Omega-3 fatty acids may prevent some forms of depression

  • Power can corrupt even the honest

  • Keeping your eyes on the prize can help with exercise, study finds

  • Predicting future course of psychotic illness

  •